Fighting Fat
Invest in

Fighting Fat


Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
76.2% Diabetes Care 2.6%
26.3% Novo Nordisk A/S ADS NVO 22.4%
24.5% Sanofi-Aventis ADS SNY 5.9%
23.5% Merck & Co. Inc. MRK 12.1%
2.0% Greatbatch GB 19.3%
16.7% Weight Management 16.2%
6.2% NutriSystem Inc NTRI 74.9%
3.3% Weight Watchers International Inc. WTW 74.0%
2.8% Medifast Inc. MED 8.8%
2.2% Nu Skin Enterprises Inc. (A) NUS 4.2%
1.2% USANA Health Sciences Inc. USNA 75.0%
1.0% Vitamin Shoppe VSI 23.1%
7.0% Weight Loss Drugs 45.3%
3.9% Arena Pharmaceuticals Inc. ARNA 47.0%
2.1% Orexigen Therapeutics Inc. OREX 40.7%
1.0% VIVUS Inc. VVUS 48.4%